Characterization of Nicotine Exposure and Urge-to-Smoke Following Use of Electronic and Conventional Cigarettes
NCT02210754 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2014-08-07
Summary
This trial was the initial characterization of the blu™ products being studied, with the purpose of gaining an understanding of the exposure to nicotine and craving reduction attained following use of blu™ e-cigarettes by adult smokers. Two types of exposures were utilized: a single controlled administration and a short-term ad lib use. As smoking behaviors vary from smoker to smoker, a controlled administration allows for some standardization of nicotine "dose" for each of the study products to better understand their uptake characteristics as well as urge reduction achieved under controlled conditions. Further evaluation under ad lib product use conditions provides insight into product self-administration behaviors that will allow subjects to achieve acceptable levels of urge reduction. Comparisons were made to evaluate differences between blu™ formulations as well as to the market-leading conventional cigarette, Marlboro Gold King Size ("Marlboro cigarette').
Conditions
- Smoking
Interventions
- OTHER
-
blu™ Classic Tobacco rechargeable (2.4% nicotine, glycerin vehicle)
electronic cigarettes
- OTHER
-
blu™ Classic Tobacco rechargeable (2.4% nicotine, glycerin/PG vehicle)
electronic cigarettes
- OTHER
-
blu™ Magnificent Menthol rechargeable (2.4% nicotine, glycerin vehicle)
electronic cigarettes
- OTHER
-
blu™ Classic Tobacco rechargeable (1.6% nicotine, glycerin vehicle)
electronic cigarettes
- OTHER
-
blu™ Classic Tobacco rechargeable (1.6% nicotine, glycerin/PG vehicle)
electronic cigarettes
- OTHER
-
Marlboro Cigarette
cigarettes
Sponsors & Collaborators
-
Lorillard Tobacco Company
lead INDUSTRY
Principal Investigators
-
Michael R. Gartner, MD · Celerion
Study Design
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2014-05-31
- Completion
- 2014-07-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes
NCT03559725 ·Status: COMPLETED ·Phase: PHASE1
-
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
NCT02870218 ·Status: COMPLETED ·Phase: PHASE2
-
United States Pre-Market Tobacco Application Pharmacokinetics
NCT03719391 ·Status: COMPLETED ·Phase: NA
-
Effects of E-Cigarettes in Menthol Smokers
NCT05949034 ·Status: COMPLETED ·Phase: NA
-
Evaluating New Nicotine Standards for Cigarettes - Project 3
NCT03194256 ·Status: COMPLETED ·Phase: NA
-
e-Cigarettes Versus NRT Gum for Smoking Cessation
NCT01925781 ·Status: TERMINATED ·Phase: PHASE4
-
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
NCT04231539 ·Status: COMPLETED ·Phase: NA
-
The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users
NCT02102100 ·Status: COMPLETED ·Phase: NA
-
E-cigarettes and Blood Vessel Function
NCT02740595 ·Status: COMPLETED ·Phase: NA
-
Effects of Electronic Cigarettes on Nicotine Concentrations
NCT01775787 ·Status: COMPLETED ·Phase: NA
-
Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2
NCT03168191 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.
NCT03700112 ·Status: COMPLETED ·Phase: NA
-
Characterize the Nicotine Uptake and Subjective Effects With Use of JUUL Electronic Nicotine Delivery Systems
NCT04123041 ·Status: COMPLETED ·Phase: NA
-
Effect of Banning Menthol Flavorant on Cigarette and E-Cigarette Use
NCT03402243 ·Status: COMPLETED ·Phase: NA
-
E-cigarette Nicotine Study
NCT04709471 ·Status: COMPLETED ·Phase: PHASE2
-
Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS
NCT04107779 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers
NCT00711100 ·Status: COMPLETED ·Phase: NA
-
Study to Characterize Puffing Topography With Use of JUUL Electronic Nicotine Delivery Systems (ENDS) in Adult, Closed-System ENDS Consumers
NCT04088175 ·Status: COMPLETED ·Phase: NA
-
Effects of Menthol in E-cigarettes on Smoking Behaviors
NCT04521647 ·Status: COMPLETED ·Phase: PHASE1
-
Single-dose Pharmacokinetics of Oral Nicotine Replacement Products
NCT01228617 ·Status: COMPLETED ·Phase: NA
-
Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users
NCT03710590 ·Status: COMPLETED ·Phase: NA
-
Electronic Cigarettes in Daily Dependent Smokers
NCT02108626 ·Status: COMPLETED ·Phase: PHASE4
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes
NCT03559751 ·Status: COMPLETED ·Phase: PHASE1